Suppression of pituitary gonadotropins by 17-ethynyl-19-nortestosterone in patients with metastatic carcinoma of the breast.
D001940:Breast; D001943:Breast Neoplasms / Q000628:therapy*; D044584:Carcinoma, Ductal / Q000628:therapy*; D006065:Gonadotropins, Pituitary / Q000652:urine*; D006801:Humans; D011374:Progesterone / Q000031:analogs & derivatives; D013739:Testosterone / Q000031:analogs & derivatives
C509324:19-nor-17-ethynyltestosterone; D006065:Gonadotropins, Pituitary; D013739:Testosterone; D011374:Progesterone
BREAST NEOPLASMS/therapy; CARCINOMA, DUCTAL/therapy; GONADOTROPINS, PITUITARY/urine; PROGESTERONE/related compounds